New Estimates of Herpes Simplex Virus Type 2 Seroprevalence in England: 'High' but Stable Seroprevalence over the Last Decade

Sexually Transmitted Diseases

Volumn 31, Issue 4, 2004, Pages 243-246

  Morris Cunnington, Marianne ^a,c   Brown, David ^b   Pimenta, Jeanne ^c   Robinson, Noah Jamie ^c   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE SYSTEM; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; PUBLIC HEALTH; RISK FACTOR; SEROPREVALENCE; SEX DIFFERENCE; UNITED KINGDOM; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGE FACTORS; ENGLAND; FEMALE; HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HUMANS; LABORATORIES; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES;

EID: 1642422789     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.OLQ.0000118081.54177.95     Document Type: Article

References (17)

1. STI surveillance [Health Protection Agency web site]. 2003. Available at: http://www.hpa.org.uk/infections/topics_az/hiv_and_sti/sti-herpes/herpes.
2. Wald A, Link K. Risk of immunodeficiency virus infection in herpes simplex virus type 2 seropositive persons: A meta-analysis. J Infect Dis 2002; 185:45-52.
3. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV transmission. Sex Transm Infect 1999; 75:3-17.
4. PHLS, DHSS&PS, Scottish ISD(D)5 Collaborative Group. Trends in sexually transmitted infections in the United Kingdom 1990-1999, 2000.
5. Johnson AM, Mercer CH, Erens B, Copas AJ, McManus S, Wellings K, et al. Sexual behaviour in Britain: Partnerships, practices and HIV risk behaviours. Lancet 2001; 358:1835-1842.
6. Fleming DT, McQuillan G, Johnson RE, Nahmias A, Aral SO, Lee FK, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1111.
7. Narouz N, Allan PS, Wade AH, Wagstaffe S. Genital herpes serotesting: A study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK. Sex Transm Infect 2003; 79:35-41.
8. Woolley PD, Chandiok S, Pumphrey J, Sharratt S, Shanley L, Bennett S. Serological prevalence of herpes simplex virus type 2 amongst GUM clinic attenders in a district general hospital setting. Int J STD AIDS 2000; 11:379-382.
9. Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S. Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health 1989; 43:53-60.
10. Osborne K, Gay NJ, Hesketh L, Morgan-Capner P, Miller E. Ten years of serological surveillance in England and Wales: Methods, results, implications and action. Int J Epidemiol 2000; 29:362-368.
11. Gopal R, Gibbs T, Slomka MJ, Whitworth J, Carpenter RM, Vyse AJ, et al. A monoclonal blocking EIA for herpes simplex virus type 2 antibody validation for seroepidemiological studies in Africa. J Virol Methods 2000; 87:71-80.
12. Vyse AJ, Gay NJ, Slomka KJ, Morgan-Capner P, Brown DWG. The burden of infection with HSV-1 and HSV-2 in England and Wales: Implications for the changing epidemiology of genital herpes. Sex Transm Infect 2000; 76:183-187.
13. Xu F, McQuillan G, Kottiri BJ, Sternberg MR, Lee FK, Nahmias A, et al. National seroprevalence and trends in herpes simplex virus type 1 and type 2 infection in the United States, 1988-2000. International Society for Sexually Transmitted Disease Research, Ottawa, Canada, July 27-30, 2003 Congress, pp 58-59.
14. Forsgren M, Skoog E, Jeansson S, Olofsson S, Giesecke J. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: Implications for STD epidemiology. Int J STD AIDS 1994; 5:113-116.
15. Gould IM, Jappy B. Trends in hospital antimicrobial prescribing after 9 years of stewardship. J Antimicrob Chemother 2000; 45:913-917.
16. Mullan HM, Munday PE. The acceptability of the introduction of a type specific herpes antibody screening test into a genitourinary medicine clinic in the United Kingdom. Sex Transm Infect 2003; 79:129-133.
17. Herpeselect ELISA sensitivity and specificity [Focus web site]. 2003. Available at: www.herpesdiagnosis.com.